- Home
- DERM vs CHMI Comparison
DERM vs CHMI Comparison
Compare DERM & CHMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- CHMI
- Stock Information
- Founded
- DERM 2014
- CHMI 2012
- Country
- DERM United States
- CHMI United States
- Employees
- DERM N/A
- CHMI N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- CHMI Real Estate Investment Trusts
- Sector
- DERM Health Care
- CHMI Real Estate
- Exchange
- DERM Nasdaq
- CHMI Nasdaq
- Market Cap
- DERM 87.4M
- CHMI 92.0M
- IPO Year
- DERM 2021
- CHMI 2013
- Fundamental
- Price
- DERM $3.74
- CHMI $3.00
- Analyst Decision
- DERM Strong Buy
- CHMI Buy
- Analyst Count
- DERM 3
- CHMI 2
- Target Price
- DERM $9.50
- CHMI $5.00
- AVG Volume (30 Days)
- DERM 61.7K
- CHMI 464.1K
- Earning Date
- DERM 11-12-2024
- CHMI 03-06-2025
- Dividend Yield
- DERM N/A
- CHMI 20.16%
- EPS Growth
- DERM N/A
- CHMI N/A
- EPS
- DERM N/A
- CHMI N/A
- Revenue
- DERM $57,771,000.00
- CHMI N/A
- Revenue This Year
- DERM N/A
- CHMI N/A
- Revenue Next Year
- DERM $36.49
- CHMI $27.78
- P/E Ratio
- DERM N/A
- CHMI N/A
- Revenue Growth
- DERM N/A
- CHMI N/A
- 52 Week Low
- DERM $2.85
- CHMI $2.50
- 52 Week High
- DERM $6.89
- CHMI $3.99
- Technical
- Relative Strength Index (RSI)
- DERM 32.80
- CHMI 65.37
- Support Level
- DERM $3.54
- CHMI $2.67
- Resistance Level
- DERM $3.99
- CHMI $2.83
- Average True Range (ATR)
- DERM 0.35
- CHMI 0.10
- MACD
- DERM 0.00
- CHMI 0.04
- Stochastic Oscillator
- DERM 21.28
- CHMI 94.51
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About CHMI Cherry Hill Mortgage Investment Corporation
Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.